Article ID Journal Published Year Pages File Type
5690525 Urology 2017 29 Pages PDF
Abstract
The use of prostate MRI in addition to the Prostate Cancer Prevention Trial risk calculator provides a significant improvement in clinical risk discrimination for patients with estimated risk of high-grade (Gleason ≥7) prostate cancer ≤10%. Prebiopsy prostate MRI should be strongly considered for these patients.
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Preview
Magnetic Resonance Imaging Provides Added Value to the Prostate Cancer Prevention Trial Risk Calculator for Patients With Estimated Risk of High-grade Prostate Cancer Less Than or Equal to 10%
Authors
, , , , , ,